Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure

被引:35
作者
Massin, N. [1 ]
Meduri, G. [2 ]
Bachelot, A. [1 ]
Misrahi, M. [3 ]
Kuttenn, F. [1 ]
Touraine, P. [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, Dept Endocrinol & Reprod Med, F-75651 Paris 13, France
[2] Hop Bicetre, INSERM, U693, Fac Med, F-94270 Le Kremlin Bicetre, France
[3] Hop Bicetre, INSERM, E120, Fac Med, F-94270 Le Kremlin Bicetre, France
关键词
premature ovarian failure; ovary; AMH;
D O I
10.1016/j.mce.2007.11.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Premature ovarian failure (POF) is a heterogeneous syndrome, possibly due to mutations of genes involved in the normal development of the ovary and/or the follicles. Based essentially on animal models, these mutations are associated with various ovarian histological phenotypes, from a complete absence of to a partial follicular maturation. The aims of our work were in one hand to determine if ovarian histology, compared to pelvic ultrasonography, would be helpful either in identifying which patients display an impaired follicular growth or in the orientation of the POF etiology; on the other hand, since developing follicles up to the antral stage are reported in POF and that Anti-Mullerian hormone (AMH) might be a good indicator of follicular presence, we decided to determine whether AMH should be a better marker to determine the presence of an ovarian reserve in POF patients. To try to answer to the first question, we studied first 166 patients suffering from POF with a normal karyotype. Vaginal ultrasonography (US) was performed in 134 patients and an ovarian biopsy was obtained in 67 women. The presence of follicles suggested at US was confirmed at histology in only 56% of the patients. Ovarian histology led to the distinction of two phenotypes (a) small-sized ovaries, deprived of follicles, and (b) normal-sized ovaries with partial follicular maturation. To confirm the value of ovarian biopsies, samples from 20 normal women have been studied, confirming that ovarian biopsy at random allow reliable assessment of follicular activity. To try to answer to the second question of our work, a cross sectional study analyzing serum AMH, ovarian histology and AMH immunoexpression in 48 POF patients, was performed. Serum AMH was significantly higher in women with more than 5 follicles at ovarian histology. Ovarian AMH immunostaining revealed a normal AMH expression in POF preantral follicles but a decrease expression at the early antral stages. In conclusion, ovarian histology appears to be a reliable tool to appreciate the follicular reserve, and helpful and complementary to clinical and hormonal phenotyping in order to orient the search for various genetic causes of POF syndrome. Finally, AMH levels in POF patients could identify women with persistent follicles. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 29 条
[11]   Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary [J].
Durlinger, ALL ;
Gruijters, MJG ;
Kramer, P ;
Karels, B ;
Ingraham, HA ;
Nachtigal, MW ;
Uilenbroek, JTJ ;
Grootegoed, JA ;
Themmen, APN .
ENDOCRINOLOGY, 2002, 143 (03) :1076-1084
[12]   Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary [J].
Durlinger, ALL ;
Kramer, P ;
Karels, B ;
de Jong, FH ;
Uilenbroek, JTJ ;
Grootegoed, JA ;
Themmen, APN .
ENDOCRINOLOGY, 1999, 140 (12) :5789-5796
[13]   Regulation of ovarian function: the role of anti-Mullerian hormone [J].
Durlinger, ALL ;
Visser, JA ;
Themmen, APN .
REPRODUCTION, 2002, 124 (05) :601-609
[14]  
Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/revreprod/3.3.183
[15]   Dynamics of serum anti-Mullerian hormone levels during the luteal phase of controlled ovarian hyperstimulation [J].
Fanchin, R ;
Lozano, DHM ;
Louafi, N ;
Achour-Frydman, N ;
Frydman, R ;
Taieb, J .
HUMAN REPRODUCTION, 2005, 20 (03) :747-751
[16]   Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3 [J].
Fanchin, R ;
Schonäuer, LM ;
Righini, C ;
Guibourdenche, J ;
Frydman, R ;
Taieb, J .
HUMAN REPRODUCTION, 2003, 18 (02) :323-327
[17]   Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol [J].
Hazout, A ;
Bouchard, P ;
Seifer, DB ;
Aussage, P ;
Junca, AM ;
Cohen-Bacrie, P .
FERTILITY AND STERILITY, 2004, 82 (05) :1323-1329
[18]   Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause [J].
La Marca, A ;
De Leo, V ;
Giulini, S ;
Orvieto, R ;
Malmusi, S ;
Giannella, L ;
Volpe, A .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (07) :545-548
[19]   Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age [J].
Laven, JSE ;
Mulders, AGMGJ ;
Visser, JA ;
Themmen, AP ;
De Jong, FH ;
Fauser, BCJM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :318-323
[20]   Significance of ovarian histology in the management of patients presenting a premature ovarian failure [J].
Massin, N ;
Gougeon, A ;
Meduri, G ;
Thibaud, E ;
Laborde, K ;
Matuchansky, C ;
Constancis, E ;
Vacher-Lavenu, MC ;
Paniel, B ;
Zorn, JR ;
Misrahi, M ;
Kuttenn, F ;
Touraine, P .
HUMAN REPRODUCTION, 2004, 19 (11) :2555-2560